Japanese food-to-pharmaceuticals group Meiji Holdings has booked a jump in annual profits on the back of efficiency gains and sales growth at its food unit.

Group-wide sales for the 12 months to the end of March rose to JPY1.22trn (US$11.18bn), versus JPY1.16trn in the prior year. Food sales increased to JPY1.06trn, while pharma revenue stood at JPY164.5bn. Revenue was positively impacted by price increases on “mainstay” products pushed through by the company to offset higher input prices, Meiji said in a regulatory filing. 

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Operating income increased to JPY77.78bn, up from JPY51.54bn in 2015. Food operating income represented JPY68.2bn, up from JPY41.6bn in the year-ago period. Meiji said its profitability benefited from efforts to “optimise production” and “reduce costs”. 

Net income at the company more than doubled, increasing to JPY62.58bn from JPY30.89bn. 

Following its results release, Meiji provided details on its plans to accelerate sales growth over the coming 12 months. Click here for more. 

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Just Food Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Just Food Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now